Mediastinal Tumor Thymoma Type B1 T4N2M1B Stage IVB with Multimodality Therapy

Muhammad Zakki Al-Fajri (Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Andalas University)
Sabrina Ermayanti (Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Andalas University)
Afriani Afriani (Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Andalas University)

Eksakta : Berkala Ilmiah Bidang MIPA
Vol. 23 No. 01 (2022): Eksakta : Berkala Ilmiah Bidang MIPA (E-ISSN : 2549-7464)

The incidence of thymoma increases with age, generally occurs in the 40-60s. Thymoma cases are rare at a young age. The prevalence of thymoma at a young age is very small at 0.6 – 5% of all thymoma cases. Thymoma management requires multimodality therapy depending on the stage of the thymoma, along with the development of surgery, radiotherapy and chemotherapy in the past three decades. A 21-year-old male patient with complaints of shortness of breath since 5 months before being admitted to the hospital. The patient has been diagnosed with thymoma type Mediastimum Tumor Type B1 T4N2M1B stage IVB from the results of chest X-ray investigations, chest CT scan, bronchoscopy and histopathological examination. The patient has received various therapeutic modalities including 6 cycles of chemotherapy, 30 radiotherapy and thymectomy surgery